{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:44:33Z","timestamp":1751449473037,"version":"3.41.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.toxrep.2025.102055","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T23:41:23Z","timestamp":1748389283000},"page":"102055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Drugs or dissection? Unraveling a diagnostic puzzle in the ED: A case report on Tizanidine-Nifedipine interaction"],"prefix":"10.1016","volume":"14","author":[{"given":"Muhammad Abd Ur","family":"Rehman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaz Uddin","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Abdul","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.toxrep.2025.102055_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003495-199753030-00007","article-title":"Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders","volume":"53","author":"Wagstaff","year":"1997","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.toxrep.2025.102055_bib2","first-page":"793","article-title":"The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (DS 103-282), a novel myotonolytic agent","volume":"30","author":"Sayers","year":"1980","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/j.toxrep.2025.102055_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000138158","article-title":"Influence of clonidine and a new related imidazoline derivative (tizanidine) on rat gastric mucosa","volume":"32","author":"Maeda-Hagiwara","year":"1986","journal-title":"Pharmacology"},{"issue":"9","key":"10.1016\/j.toxrep.2025.102055_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.toxrep.2025.102055_bib5","doi-asserted-by":"crossref","unstructured":"Jones K.E., Hayden S.L., Meyer H.R., et al. The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations. Curr Issues Mol Biol. 2024;46(7):6315-6327. Published 2024 Jun 22. doi:10.3390\/cimb4607037.","DOI":"10.3390\/cimb46070377"},{"issue":"19","key":"10.1016\/j.toxrep.2025.102055_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.2146\/ajhp090657","article-title":"Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy","volume":"67","author":"Publow","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"12","key":"10.1016\/j.toxrep.2025.102055_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/088307380001501211","article-title":"Hypotension following the initiation of tizanidine in a patient treated with an angiotensin converting enzyme inhibitor for chronic hypertension","volume":"15","author":"Johnson","year":"2000","journal-title":"J. Child Neurol."},{"issue":"11","key":"10.1016\/j.toxrep.2025.102055_bib8","first-page":"1840","article-title":"Hypotension due to interaction between lisinopril and tizanidine","volume":"38","author":"Kao","year":"2004","journal-title":"Ann. Pharm."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102055_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1574886318666230725113855","article-title":"Tizanidine induced hypotension: report of a case and review of the literature","volume":"19","author":"Mahajan","year":"2024","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.toxrep.2025.102055_bib10","unstructured":"National Center for Health Statistics. Emergency Department Visits in the United States, 2016-2022. Generated interactively: November 21, 2024 from \u3008https:\/\/www.cdc.gov\/nchs\/dhcs\/ed-visits\/index.htm\u3009."},{"key":"10.1016\/j.toxrep.2025.102055_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejim.2024.05.029","article-title":"Diagnosis of acute aortic syndromes with ultrasound and d-dimer: the PROFUNDUS study","volume":"128","author":"Morello","year":"2024","journal-title":"Eur. J. Intern Med."},{"issue":"8","key":"10.1016\/j.toxrep.2025.102055_bib12","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1161\/HYP.0000000000000238","article-title":"The management of elevated blood pressure in the acute care setting: a scientific statement from the American heart association","volume":"81","author":"Bress","year":"2024","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.toxrep.2025.102055_bib13","first-page":"e426","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.toxrep.2025.102055_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2017.00286","article-title":"Discovery and development of calcium channel blockers","volume":"8","author":"Godfraind","year":"2017","journal-title":"Front. Pharm."},{"issue":"11","key":"10.1016\/j.toxrep.2025.102055_bib15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00004872-199816090-00017","article-title":"Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients","volume":"16","author":"de Champlain","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.toxrep.2025.102055_bib16","series-title":"Hypertensive urgencies and emergencies","first-page":"761","author":"Grossman","year":"2007"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102055_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-3565(25)38136-X","article-title":"Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2","volume":"265","author":"Tassaneeyakul","year":"1993","journal-title":"J. Pharm. Exp. Ther."},{"issue":"11-12","key":"10.1016\/j.toxrep.2025.102055_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s002280050706","article-title":"Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions","volume":"55","author":"Katoh","year":"2000","journal-title":"Eur. J. Clin. Pharm."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102055_bib19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-6576.1995.tb04139.x","article-title":"The metabolic effects of oral tizanidine in healthy volunteers","volume":"39","author":"Taittonen","year":"1995","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102055_bib20","first-page":"9","article-title":"Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury","volume":"26","author":"Mathias","year":"1989","journal-title":"J. Rehabil. Res Dev."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102055_bib21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cpt.1233","article-title":"Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study","volume":"105","author":"Chaugai","year":"2019","journal-title":"Clin. Pharm. Ther."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102055_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00228-008-0469-7","article-title":"Tizanidine-induced hypotension in patients with liver cirrhosis","volume":"64","author":"Momo","year":"2008","journal-title":"Eur. J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102055_bib23","first-page":"674","article-title":"Proposal for a new tool to evaluate drug interaction cases","volume":"41","author":"Horn","year":"2007","journal-title":"Ann. Pharm."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025001738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025001738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:48:15Z","timestamp":1750207695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750025001738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":23,"alternative-id":["S2214750025001738"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102055","relation":{},"ISSN":["2214-7500"],"issn-type":[{"type":"print","value":"2214-7500"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs or dissection? Unraveling a diagnostic puzzle in the ED: A case report on Tizanidine-Nifedipine interaction","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102055"}}